MIC2 analysis of small cell carcinoma

Jeanne Ann Lumadue, F. B. Askin, E. J. Perlman

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Small cell carcinomas (SCCs) and peripheral neuroectodermal tumors (PNETs) are two distinct neoplasms that show considerable histologic, immunohistochemical, and clinical overlap, but differ in their therapies and prognoses. In an attempt to further diagnostically distinguish the two, 33 SSCs were analyzed from both pulmonary and extrapulmonary sites for the MIC2 gene product, a cell surface antigen strongly and reliably expressed in PNETs and Ewing's sarcoma (ES). Two of the 33 SCCs stained positively, but the staining was less intense than that seen with PNET and ES. The remaining 31 tumors did not stain. These data indicate that, in combination with a panel of immunohistochemical stains, analysis of neuroendocrine tumors for MIC2 expression may be useful in distinguishing between small cell carcinomas of both pulmonary and extrapulmonary origins and soft tissue PNETs.

Original languageEnglish (US)
Pages (from-to)692-694
Number of pages3
JournalAmerican Journal of Clinical Pathology
Volume102
Issue number5
DOIs
StatePublished - Jan 1 1994

Fingerprint

Peripheral Primitive Neuroectodermal Tumors
Small Cell Carcinoma
Ewing's Sarcoma
Coloring Agents
Lung
Neuroendocrine Tumors
Surface Antigens
Neoplasms
Staining and Labeling
Genes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Lumadue, Jeanne Ann ; Askin, F. B. ; Perlman, E. J. / MIC2 analysis of small cell carcinoma. In: American Journal of Clinical Pathology. 1994 ; Vol. 102, No. 5. pp. 692-694.
@article{fce38007d914466ba900142694bb0188,
title = "MIC2 analysis of small cell carcinoma",
abstract = "Small cell carcinomas (SCCs) and peripheral neuroectodermal tumors (PNETs) are two distinct neoplasms that show considerable histologic, immunohistochemical, and clinical overlap, but differ in their therapies and prognoses. In an attempt to further diagnostically distinguish the two, 33 SSCs were analyzed from both pulmonary and extrapulmonary sites for the MIC2 gene product, a cell surface antigen strongly and reliably expressed in PNETs and Ewing's sarcoma (ES). Two of the 33 SCCs stained positively, but the staining was less intense than that seen with PNET and ES. The remaining 31 tumors did not stain. These data indicate that, in combination with a panel of immunohistochemical stains, analysis of neuroendocrine tumors for MIC2 expression may be useful in distinguishing between small cell carcinomas of both pulmonary and extrapulmonary origins and soft tissue PNETs.",
author = "Lumadue, {Jeanne Ann} and Askin, {F. B.} and Perlman, {E. J.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1093/ajcp/102.5.692",
language = "English (US)",
volume = "102",
pages = "692--694",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

MIC2 analysis of small cell carcinoma. / Lumadue, Jeanne Ann; Askin, F. B.; Perlman, E. J.

In: American Journal of Clinical Pathology, Vol. 102, No. 5, 01.01.1994, p. 692-694.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MIC2 analysis of small cell carcinoma

AU - Lumadue, Jeanne Ann

AU - Askin, F. B.

AU - Perlman, E. J.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Small cell carcinomas (SCCs) and peripheral neuroectodermal tumors (PNETs) are two distinct neoplasms that show considerable histologic, immunohistochemical, and clinical overlap, but differ in their therapies and prognoses. In an attempt to further diagnostically distinguish the two, 33 SSCs were analyzed from both pulmonary and extrapulmonary sites for the MIC2 gene product, a cell surface antigen strongly and reliably expressed in PNETs and Ewing's sarcoma (ES). Two of the 33 SCCs stained positively, but the staining was less intense than that seen with PNET and ES. The remaining 31 tumors did not stain. These data indicate that, in combination with a panel of immunohistochemical stains, analysis of neuroendocrine tumors for MIC2 expression may be useful in distinguishing between small cell carcinomas of both pulmonary and extrapulmonary origins and soft tissue PNETs.

AB - Small cell carcinomas (SCCs) and peripheral neuroectodermal tumors (PNETs) are two distinct neoplasms that show considerable histologic, immunohistochemical, and clinical overlap, but differ in their therapies and prognoses. In an attempt to further diagnostically distinguish the two, 33 SSCs were analyzed from both pulmonary and extrapulmonary sites for the MIC2 gene product, a cell surface antigen strongly and reliably expressed in PNETs and Ewing's sarcoma (ES). Two of the 33 SCCs stained positively, but the staining was less intense than that seen with PNET and ES. The remaining 31 tumors did not stain. These data indicate that, in combination with a panel of immunohistochemical stains, analysis of neuroendocrine tumors for MIC2 expression may be useful in distinguishing between small cell carcinomas of both pulmonary and extrapulmonary origins and soft tissue PNETs.

UR - http://www.scopus.com/inward/record.url?scp=0028075616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028075616&partnerID=8YFLogxK

U2 - 10.1093/ajcp/102.5.692

DO - 10.1093/ajcp/102.5.692

M3 - Article

C2 - 7524308

AN - SCOPUS:0028075616

VL - 102

SP - 692

EP - 694

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -